- Home
- TAK vs FANG Comparison
TAK vs FANG Comparison
Compare TAK & FANG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TAK
- FANG
- Stock Information
- Founded
- TAK 1781
- FANG 2007
- Country
- TAK Japan
- FANG United States
- Employees
- TAK N/A
- FANG N/A
- Industry
- TAK Biotechnology: Pharmaceutical Preparations
- FANG Oil & Gas Production
- Sector
- TAK Health Care
- FANG Energy
- Exchange
- TAK Nasdaq
- FANG Nasdaq
- Market Cap
- TAK 42.2B
- FANG 50.6B
- IPO Year
- TAK N/A
- FANG 2012
- Fundamental
- Price
- TAK $15.04
- FANG $145.80
- Analyst Decision
- TAK
- FANG Buy
- Analyst Count
- TAK 0
- FANG 21
- Target Price
- TAK N/A
- FANG $213.38
- AVG Volume (30 Days)
- TAK 1.5M
- FANG 3.1M
- Earning Date
- TAK 05-08-2025
- FANG 04-29-2025
- Dividend Yield
- TAK 3.39%
- FANG 4.26%
- EPS Growth
- TAK 15.39
- FANG N/A
- EPS
- TAK 0.83
- FANG 15.53
- Revenue
- TAK $29,124,927,177.00
- FANG $10,561,000,000.00
- Revenue This Year
- TAK $8.53
- FANG $47.43
- Revenue Next Year
- TAK N/A
- FANG N/A
- P/E Ratio
- TAK $36.00
- FANG $9.39
- Revenue Growth
- TAK 9.83
- FANG 32.69
- 52 Week Low
- TAK $12.58
- FANG $137.09
- 52 Week High
- TAK $15.22
- FANG $214.50
- Technical
- Relative Strength Index (RSI)
- TAK 70.24
- FANG 39.55
- Support Level
- TAK $14.83
- FANG $137.09
- Resistance Level
- TAK $15.22
- FANG $148.36
- Average True Range (ATR)
- TAK 0.17
- FANG 5.53
- MACD
- TAK 0.03
- FANG -0.04
- Stochastic Oscillator
- TAK 84.84
- FANG 35.73
About TAK Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.3 trillion in fiscal 2023. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with 50% derived from the US, 20% from Japan, 20% from Europe and Canada.
About FANG Diamondback Energy Inc.
Diamondback Energy is an independent oil and gas producer in the United States. The company operates exclusively in the Permian Basin. At the end of 2023, the company reported net proven reserves of 2.2 billion barrels of oil equivalent. Net production averaged about 448,000 barrels per day in 2023, at a ratio of 59% oil, 21% natural gas liquids, and 20% natural gas.